- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01432067
Physical Activity Advices to Prevent Loss of Autonomy in Cancer Treated Elderly Patients. An Intervention Randomized Study (CAPADOGE)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Long-term evolution of successful-treated older patients is not well-known except for survival. They seem more affected by physical than psychological problems. The combined effects of aging, cancer, and treatments on muscle function could have hindered their usual physical activity. Cancer is associated with frailty. Fried and coll have defined a frailty phenotype as a combination of 3 or more of 5 conditions: exhaustion, loss of weight, decreased muscle strength, slow gait speed and low physical activity. Frail subjects have a higher risk of physical or cognitive disability and death. An intervention able to prevent frailty is of great interest for the older cancer patient and their quality of life. An intervention consisting of phone-program in physical activity has been associated with a decrease in self-reported disability in five-year obese survivors from cancer.
Patients will be randomized in two arms (1:1 ratio). Arm 1: Physical activity advices according to a program adapted to physical status of the patient assessed using SPPB (short physical performance battery) and the IPAQ questionnaire. A monthly phone support during one year will be performed by an adapted physical activity instructor and delivery of PNNS guide for subjects older than 55 y old. Arm 2: Delivery of PNNS guide for subjects older than 55 year old: recommendation of 1/2 hour physical activity of any kind.
Each patient will be followed during 2 years: First visit (V1) will take place before treatment. The subsequent visits will take place at 3 months (V2), 6 months (V3), 1 year (V4), 18 months (V5) and 2 years (V6), in which patients will complete questionnaires (IPAQ, QLQ-C30, one day dietary intakes), have clinical examinations (weight, performance status/ ECOG) and will be tested for physical facilities (SPPB, micro-fet2). These evaluations will be completed by the MMS / Fluency tests and the covered distance during 6 minutes at V1, V3, and V4.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Bordeaux, France, 33076
- Institut Bergonie
-
Bordeaux, France, 33000
- CHU de Bordeaux - Hopital Saint Andre
-
Dax, France
- CH de Dax
-
Lille, France, 59000
- CHRU Lille
-
Lille, France, 59020
- Centre Oscar Lambret, CLCC Lille
-
Limoges, France, 87042
- CHU de Limoges, Hopital Dupuytren
-
Mont de Marsan, France
- CH Mont de Marsan
-
Pessac, France, 33604
- CHU Bordeaux - hôpital Xavier Arnozan
-
Reims, France, 51056
- Institut jean Godinot, CLCC Reims
-
Senlis, France, 60309
- Centre hospitalier de Senlis
-
Vandœuvre-Les-Nancy, France, 54511
- Centre Alexis Vautrin CLCC Nancy
-
Vandœuvre-Les-Nancy, France, 54511
- CHU Nancy hôpital adulte du brabois
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 70 years old or older
- Curative cares for cancer by chemotherapy and/ or surgery and/or hormonotherapy and/ or radiotherapy
Patient with histologically proven lymphoma or carcinoma :
- Colon, rectum or anal canal Cancer
- Breast Cancer
- Esophageal cancer
- Otolaryngology Cancer
- Kidney cancer
- hepatocellular carcinoma
- Stomach Cancer
- Pancreatic cancer
- Bile duct cancer
- Ovarian Cancer
- All lymphoma diffuse large B-cell and all peripheral T-cells lymphomas
- All low-grade lymphoma: lymphocytes, lymphocytes and plasma cells, follicular, mantle, marginal zone (MALT and others)
- Prostate cancer
- Bladder Cancer
- Lung cancer
- adenocarcinoma of unknown primary origin compatible with previous quoted origin
- Performance status (ECOG) <4
- Patient who had given oral consent to participate in the study
Exclusion Criteria:
- Palliative cares for cancer
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Adaptated physical activity
Physical activity advices adaptated to physical status of patients
|
Physical activity advices according to a program adapted to physical status of the patient.
|
Other: Standard physical activity
Daily physical activities based on a standard guide
|
Daily physical activities based on a standard guide
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
SPPB Score
Time Frame: 1 year
|
The main outcome will be the proportion of subjects with a one-year decreased SPPB score of one point or more in 12.
|
1 year
|
Cognitive skills
Time Frame: 2 years
|
MMS test, verbal fluency
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life
Time Frame: 2 years
|
IPAQ, QLQ-C30, ADL, performance status (ECOG)
|
2 years
|
nutritional status
Time Frame: 2 years
|
2 years
|
|
Walking distance over 6 minutes
Time Frame: inclusion, 6 months and 1 year
|
inclusion, 6 months and 1 year
|
|
isometric muscle strength measures of upper and lower limbs
Time Frame: 2 years
|
microfet2 test
|
2 years
|
weight
Time Frame: 2 years
|
2 years
|
|
SPPB score
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Isabelle BOURDEL MARCHASSON, Pr, University Hospital, Bordeaux, France
- Study Chair: Adélaïde DOUSSAU, Dr, University Hospital, Bordeaux, France
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CHUBX 2010/23
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
University of Michigan Rogel Cancer CenterRecruitingCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterHyundai Hope On WheelsRecruitingCancer | Pediatric Cancer | Survivorship | Cancer MetastaticUnited States
-
Vanderbilt-Ingram Cancer CenterNational Institutes of Health (NIH)Active, not recruitingAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedStage I Breast Cancer | Stage I Uterine Corpus Cancer | Stage II Uterine Corpus Cancer | Stage III Uterine Corpus Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage... and other conditionsUnited States
-
Massachusetts General HospitalNational Comprehensive Cancer NetworkCompletedGastric Cancer | Pancreatic Cancer | Esophageal Cancer | Rectal Cancer | Colon Cancer | Hepatobiliary CancerUnited States
-
Johns Hopkins UniversityNational Cancer Institute (NCI); National Institute on Minority Health and...Enrolling by invitationCancer | Advanced Cancer | End Stage Cancer | MalignancyUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
Clinical Trials on Adapted physical activity
-
Assistance Publique Hopitaux De MarseilleNot yet recruiting
-
University Hospital, CaenNot yet recruitingChronic Pain | Multiple Myeloma | Adapted Physical Activity
-
Central Hospital, Nancy, FranceRecruiting
-
WepromRecruitingLymphoma | Myeloma | Autologous TransplantFrance
-
Centre Hospitalier Universitaire de NiceCompleted
-
Support and Education Technic CentreCompletedHeart Failure | Cardiovasculars Risk FactorsFrance, Cameroon
-
University of LausanneCompletedPostural ControlSwitzerland
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
University Hospital, AngersNot yet recruitingCardio-Respiratory FailureFrance
-
Mon Stade Sports Medicine CentreLaboratory MOVE, Faculty of Sport Sciences, University of Poitiers, France; Public Health Foundation of MGEN, France and other collaboratorsRecruitingPhysical Activity | Life Style, Healthy | Adherence, Patient | Life Style | Cost-Benefit Analysis | Behavior and Behavior Mechanisms | Exercise Therapy | Adapted Physical Activity | Lifestyle, Sedentary | PrescriptionsFrance